Article Text

Download PDFPDF
Incidental splenomegaly in a teenager
  1. Veronika Baghin1,
  2. Seraina Prader1,
  3. Selma Sirin2,
  4. Jana Pachlopnik Schmid1,
  5. Johannes Trück1,3
  1. 1 Division of Immunology, University Children’s Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland
  2. 2 Department of Diagnostic Imaging, Children’s Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland
  3. 3 University Children's Hospital Zürich, Zurich, Switzerland
  1. Correspondence to Dr Johannes Trück, University Children's Hospital Zürich, Zurich CH-8032, Switzerland; johannes.trueck{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A healthy male teenager presented to his primary care paediatrician for a routine check-up including receipt of vaccines. On clinical examination, isolated splenomegaly was noted, a few days later confirmed by MRI (figure 1). Extensive investigations excluded an underlying oncological, infectious or metabolic disease. Due to bicytopenia (haemoglobin 69 g/L, white blood count 1.52×109/L, platelet count 151×109/L) with suspected autoimmune pathogenesis, extended immunological diagnostics were performed. This revealed an increased serum IgG concentration (19.3 g/L (5.9–12.5)) and an increase in double-negative T cells (DNT) (14.7%, <6%) by flow cytometry of peripheral blood lymphocytes. In addition, serum vitamin B12 (1530 pg/mL (182–1090)) and soluble Fas ligand levels (2428 pg/mL, <250) were elevated. In view of these highly suggestive findings of autoimmune lymphoproliferative syndrome (ALPS), functional and genetic diagnostics were performed to confirm the suspected diagnosis. Genetic investigation revealed a previously unknown heterozygous variant in FAS (NM_000043.6:c.806A>T, p.Asp269Val, not present in gnomAD), which was functionally verified …

View Full Text


  • Twitter @jtrueck

  • Contributors VB, SP, SS, JPS and JT: involved with patient care and/or diagnostic workup and critically reviewed the manuscript. VB and JT: drafted the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.